[go: up one dir, main page]

AU2003259301A1 - Ophtalmic compositions - Google Patents

Ophtalmic compositions

Info

Publication number
AU2003259301A1
AU2003259301A1 AU2003259301A AU2003259301A AU2003259301A1 AU 2003259301 A1 AU2003259301 A1 AU 2003259301A1 AU 2003259301 A AU2003259301 A AU 2003259301A AU 2003259301 A AU2003259301 A AU 2003259301A AU 2003259301 A1 AU2003259301 A1 AU 2003259301A1
Authority
AU
Australia
Prior art keywords
ophtalmic
compositions
ophtalmic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003259301A
Other versions
AU2003259301A8 (en
Inventor
George W. Ousler Iii
Min-Shyan Sheu
Shih-Horng Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ophthalmic Research Associates Inc
AST Products Inc
Original Assignee
AST Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/207,375 external-priority patent/US6828356B2/en
Priority claimed from US10/207,376 external-priority patent/US6806364B2/en
Application filed by AST Products Inc filed Critical AST Products Inc
Publication of AU2003259301A8 publication Critical patent/AU2003259301A8/en
Publication of AU2003259301A1 publication Critical patent/AU2003259301A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08Cellulose derivatives
    • C08L1/26Cellulose ethers
    • C08L1/28Alkyl ethers
    • C08L1/284Alkyl ethers with hydroxylated hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/745Polymers of hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
AU2003259301A 2002-07-29 2003-07-29 Ophtalmic compositions Abandoned AU2003259301A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/207,375 US6828356B2 (en) 2002-07-29 2002-07-29 Preparation of ophthalmic compositions
US10/207,376 2002-07-29
US10/207,376 US6806364B2 (en) 2002-07-29 2002-07-29 Ophthalmic compositions
US10/207,375 2002-07-29
PCT/US2003/023781 WO2004011544A1 (en) 2002-07-29 2003-07-29 Ophtalmic compositions

Publications (2)

Publication Number Publication Date
AU2003259301A8 AU2003259301A8 (en) 2004-02-16
AU2003259301A1 true AU2003259301A1 (en) 2004-02-16

Family

ID=31190685

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003259301A Abandoned AU2003259301A1 (en) 2002-07-29 2003-07-29 Ophtalmic compositions

Country Status (3)

Country Link
AU (1) AU2003259301A1 (en)
CA (1) CA2494449A1 (en)
WO (1) WO2004011544A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR048523A1 (en) * 2004-04-07 2006-05-03 Kalypsys Inc COMPOUNDS WITH ARIL SULFONAMIDE AND SULFONYL STRUCTURE AS PPAR MODULATORS AND METHODS TO TREAT METABOLIC DISORDERS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409904A (en) * 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
US5607698A (en) * 1988-08-04 1997-03-04 Ciba-Geigy Corporation Method of preserving ophthalmic solution and compositions therefor
US5770592A (en) * 1991-11-22 1998-06-23 Alcon Laboratories, Inc. Prevention and treatment of ocular neovascularization using angiostatic steroids
US5888493A (en) * 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
US6265444B1 (en) * 1997-05-23 2001-07-24 Insite Vision Incorporated Ophthalmic composition

Also Published As

Publication number Publication date
WO2004011544A1 (en) 2004-02-05
AU2003259301A8 (en) 2004-02-16
CA2494449A1 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
AU2003239909A1 (en) Enhanced-service provision
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones
AU2003285288A1 (en) Composition
AU2003259290A1 (en) Glass compositions
WO2003072535A8 (en) Substituted hydroxyethylamines
AU2003238043A1 (en) Substituted imidazotriazines
AU2003245984A1 (en) Hetero-cyclicaly substituted imidazotriazines
AU2002950744A0 (en) Composition
AU2003235708A1 (en) Polytartrate composition
AU2003294900A1 (en) Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides
AU2003208411A1 (en) Anti-glycolytic composition
AU2003269904A1 (en) Antigen-polymer compositions
AU2003217110A1 (en) Novel formulation
AU2002354472A1 (en) Combine
AU2003212366A1 (en) Substituted 4-aminocyclohexanols
AU2003301902A1 (en) Cosmetic compositions
AU2002355026A1 (en) Combine
AU2003208841A1 (en) Gasolinen compositions
AU2003100144A4 (en) Lousicide composition
AU2003235722A1 (en) Polymeric compositions
AU2003216382A1 (en) Idothyronine compositions
AU2003268772A1 (en) Oil-barrier composition
AU2003259301A1 (en) Ophtalmic compositions
AU2003218497A1 (en) FACTORVIIa COMPOSITIONS
AU2003235937A1 (en) Rubber composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase